Abiopharma

Rapid Micro Biosystems to Announce Second Quarter 2025 Financial Results on August 12, 2025

SenesTech to Report Second Quarter 2025 Financial Results on Thursday, August 7, 2025

Avanos Announces Divestiture of Hyaluronic Acid Product Line to Channel-Markers Medical

New Form 10-Q - FibroBiologics, Inc. Filed: 2025-07-31 AccNo: 0000950170-25-100917 Size: 8 MB

New Form 8-K - BIO-RAD LABORATORIES, INC. Filed: 2025-07-31 AccNo: 0000012208-25-000051 Size: 2 MB Item 2.02: Results of Operations and Financial Condition Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits

New Form 8-K - Ultragenyx Pharmaceutical Inc. Filed: 2025-07-31 AccNo: 0000950170-25-100918 Size: 154 KB Item 8.01: Other Events

Bio-Rad - Bio-Rad Reports Second-Quarter 2025 Financial Results

Eastman Chemical Company - Eastman Announces Second-Quarter 2025 Financial Results

New Form 4 - DBV Technologies S.A. Filed: 2025-07-31 AccNo: 0001415889-25-020722 Size: 5 KB

BD Aims to Save Lives by Empowering Women with Choice and Access to Cervical Cancer Screening Self-Collected At Home

Larimar Therapeutics Announces Closing of Underwritten Public Offering of Common Stock and Exercise in Full of the Underwriters’ Option to Purchase Additional Shares

Bio-Rad Reports Second-Quarter 2025 Financial Results

Certara Appoints Dr. Chris Bouton as Chief Technology Officer to Advance AI in-silico Drug Discovery and Development Platform

New Form 10-Q - OPKO HEALTH, INC. Filed: 2025-07-31 AccNo: 0000950170-25-100908 Size: 18 MB

New Form 8-K - STRYKER CORP Filed: 2025-07-31 AccNo: 0000310764-25-000103 Size: 1 MB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits